drugset / Trial / NCT04839237
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This studay evaluates the effect of liraglutide in the treatment of obese patients ande the influence of genetic factors on the curative effect.Half of participants will receive Liraglutide alone,while the other half who can not achieving adequate glycaemic control will receive Liraglutide and metformin in combination.
Timeline
- Start
- 2017-12-01
- Primary completion
- 2020-12-01
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 1.8 mg | Subcutaneous |
| Background | Metformin | Small molecule | 0.5 g | Oral |